Applied Clinical Trials-06-01-2025

View the Applied Clinical Trials June 2025 issue in an interactive format.

In our June issue, explore how clinical research is adapting to regulatory changes, AI advancements, and modernizing trial designs for improved safety and efficiency.

Balancing the emerging benefits of AI in pharmacovigilance with new responsibilities and demands from regulators in enhancing efficiency and safety.

Navigating a complex drug development landscape, sponsors must rethink their approach to risk in study design and execution.

Advancing more inclusive and representative clinical trials through action and accountability.

The importance of applying past lessons to align clinical development with scientific advancement.

Clinical research evolves to prioritize patient-centered outcomes, integrating accessibility standards in electronic data capture for inclusive clinical trials.

Exploring stat-based testing for variables that identify deliberate data manipulation in clinical trials.

Clinical trials face a critical challenge: bridging the gap between patient curiosity and motivation to participate, impacting recruitment success.

Strategies for sponsors in navigating the European Union's new health technology assessment regulation.

Recent analysis explores AI's momentum in drug development, showcasing rapid adoption and significant time savings, despite challenges in trust and data governance.

Overcoming the illusion of knowledge in clinical research can enhance decision-making, training, and project success—helping ensure trials run smoothly and effectively.

Understanding the benefits and concerns associated with implementing datasets into clinical trial workflows.

Unlocking the full potential of artificial intelligence requires these stakeholders to ensure their data are accessible and secure.